Literature DB >> 18188529

Increased susceptibility of serum and apo-B-containing lipoproteins to peroxidation in aged rats.

B Depboylu1, S Doğru-Abbasoğlu, G Aykaç-Toker, M Uysal.   

Abstract

Oxidative modifications of apo-B-containing lipoproteins (LDL+VLDL) appear to play a role in atherogenesis. Increased atherosclerosis is one of the major causes of morbidity and mortality during ageing. The aim of this study was to investigate the susceptibility of serum and LDL+VLDL to lipid peroxidation in 12 young (6 months) and 12 old (22 months) rats. Serum endogenous malondialdehyde (MDA) and diene conjugate (DC) levels were found to be increased by 24.9% and 30.0% respectively, in old rats. In addition, 2,2'-azobis-(2-amidinopropane) hydrochloride (AAPH)-induced lipid peroxide levels were increased in serum of old rats. Although serum vitamin E levels were significantly increased (27.4%), there was a significant decrease in cholesterol-adjusted vitamin E levels (14.3%) in old rats. Serum vitamin C and total sulphydryl levels were found to be decreased by 25.5% and 22.7% respectively. The ferric reducing ability of plasma (FRAP) was also lower (15.9%) in old rats. Endogenous DC and copper-induced MDA levels were significantly higher (65.1% and 26.7% respectively) in LDL+VLDL fractions obtained from EDTA-plasma by dextrane sulphate and MgCl(2) solution in old rats. The propagation rate and maximal amount of DC increased, but the lag phase and t (max) were shortened in LDL+VLDL fractions of old rats. Our results clearly indicate that the susceptibility of whole serum and LDL+VLDL fractions to lipid peroxidation is increased in aged rats.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18188529     DOI: 10.1007/s10238-007-0141-z

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  41 in total

Review 1.  Oxidants and antioxidants in atherosclerosis.

Authors:  R Mashima; P K Witting; R Stocker
Journal:  Curr Opin Lipidol       Date:  2001-08       Impact factor: 4.776

2.  Cardiovascular aging is associated with vitamin E increase.

Authors:  Bernd van der Loo; Ralf Labugger; Claude P Aebischer; Jeremy N Skepper; Markus Bachschmid; Volker Spitzer; Juliane Kilo; Lukas Altwegg; Volker Ullrich; Thomas F Lüscher
Journal:  Circulation       Date:  2002-04-09       Impact factor: 29.690

3.  Measurement of oxidizability of blood plasma.

Authors:  A Kontush; U Beisiegel
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

4.  Increased hepatic lipid peroxidation in aged mice.

Authors:  M Uysal; S Seckin; N Kocak-Toker; H Oz
Journal:  Mech Ageing Dev       Date:  1989-04       Impact factor: 5.432

5.  Lipid peroxidation and antioxidant enzymes in livers and brains of aged rats.

Authors:  S Doğru-Abbasoğlu; S Tamer-Toptani; B Uğurnal; N Koçak-Toker; G Aykaç-Toker; M Uysal
Journal:  Mech Ageing Dev       Date:  1997-11       Impact factor: 5.432

6.  Anti-oxidant defences and peroxidation in liver and brain of aged rats.

Authors:  G Barja de Quiroga; R Pérez-Campo; M López Torres
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

7.  Change of the lipid hydroperoxide level in mouse organs on ageing.

Authors:  S Tokumaru; H Iguchi; S Kojo
Journal:  Mech Ageing Dev       Date:  1996-01-05       Impact factor: 5.432

8.  Serum pro-oxidant-antioxidant balance and low-density lipoprotein oxidation in healthy subjects with different cholesterol levels.

Authors:  J Balkan; S Doğru-Abbasoğlu; G Aykaç-Toker; M Uysal
Journal:  Clin Exp Med       Date:  2004-04       Impact factor: 3.984

9.  Studies on lipid peroxidation and protein oxidation in the aging brain.

Authors:  M Cini; A Moretti
Journal:  Neurobiol Aging       Date:  1995 Jan-Feb       Impact factor: 4.673

10.  A rapid and simple method for measuring the susceptibility of low-density-lipoprotein and very-low-density-lipoprotein to copper-catalyzed oxidation.

Authors:  A Zhang; J Vertommen; L Van Gaal; I De Leeuw
Journal:  Clin Chim Acta       Date:  1994-06       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.